Drugs / MPHOSPH1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01259505 | Dec 2009 → Jun 2012 | breast cancer | Tokyo Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPHOSPH1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01259505 ↗ |
| Route | Subcutaneous | “CDCA1，URLC10，KIF20A，DEPDC1 and MPHOSPH1 peptides (0.5, 1 or 2mg of each peptide) mixed with Montanide ISA 51 will be administered by subcutaneous injection.” NCT01259505 ↗ |